XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Revenues $ 233,600 $ 30,700 $ 357,700 $ 126,500
Cost of goods sold 18,243 24,733
Gross profit 215,357 30,700 332,967 126,500
Operating Expenses:        
Research and development 1,320,030 809,824 3,690,495 2,944,460
General and administrative 1,182,320 2,325,319 5,507,524 9,182,132
Total Operating Expenses 2,502,350 3,135,143 9,198,019 12,126,592
Loss From Operations (2,286,993) (3,104,443) (8,865,052) (12,000,092)
Other (Income) Expense:        
Interest income (158,547) (61,667) (497,089) (176,070)
Grant income (83,333) (83,333)
Other income (566) (33,951) (150,498) (150,423)
Gain on exchange of warrants (1,711,698)
Change in fair value of warrant liabilities (1,036,464) (7,693,753) 837,466 (3,476,556)
Total Other (Income) Expense (1,195,577) (7,872,704) (1,521,819) (3,886,382)
Net (Loss) Income $ (1,091,416) $ 4,768,261 $ (7,343,233) $ (8,113,710)
Net (Loss) Income Per Share - Basic $ (0.13) $ 1.04 $ (0.96) $ (2.00)
Net (Loss) Income Per Share - Diluted $ (0.13) $ 0.39 $ (0.96) $ (2.00)
Weighted Average Common Shares Outstanding - Basic 8,121,499 4,570,843 7,643,437 4,061,975
Weighted Average Common Shares Outstanding - Diluted 8,121,499 12,324,766 7,643,437 4,061,975